Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways

Journal of Investigative Dermatology

Volumn 131, Issue 2, 2011, Pages 382-390

  Wanke, Ines ^a   Steffen, Heiko ^a   Christ, Christina ^a   Krismer, Bernhard ^a   Götz, Friedrich ^a   Peschel, Andreas ^a   Schaller, Martin ^a   Schittek, Birgit ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RIBONUCLEASE; RIBONUCLEASE 7; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; COMMENSAL; ENZYME ACTIVATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 78651383015     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.328     Document Type: Article

References (37)

1. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-50
2. Chen X, Niyonsaba F, Ushio H et al. (2005) Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 40:123-32
3. Chung WO, Dale BA (2004) Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 72:352-8
4. Cogen AL, Nizet V, Gallo RL (2008) Skin microbiota: a source of disease or defence? Br J Dermatol 158:442-55
5. Dinulos JG, Mentele L, Fredericks LP et al. (2003) Keratinocyte expression of human beta defensin 2 following bacterial infection: role in cutaneous host defense. Clin Diagn Lab Immunol 10:161-6
6. Fujisawa H, Kondo S, Wang B et al. (1997) The expression and modulation of IFN-alpha and IFN-beta in human keratinocytes. J Interferon Cytokine Res 17:721-5
7. Fulton C, Anderson GM, Zasloff M et al. (1997) Expression of natural peptide antibiotics in human skin. Lancet 350:1750-1
8. Garcia JR, Jaumann F, Schulz S et al. (2001) Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 306:257-64
9. Harder J, Bartels J, Christophers E et al. (1997) A peptide antibiotic from human skin. Nature 387:861
10. Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-13
11. Harder J, Meyer-Hoffert U, Teran LM et al. (2000) Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 22:714-21
12. Harder J, Meyer-Hoffert U, Wehkamp K et al. (2004) Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 123:522-9
13. Harder J, Schroder JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277:46779-84
14. Harder J, Schroder JM (2005) Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 77:476-86
15. Kisich KO, Howell MD, Boguniewicz M et al. (2007) The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127:2368-80
16. Krisanaprakornkit S, Kimball JR, Dale BA (2002) Regulation of human beta-defensin-2 in gingival epithelial cells: the involvement of mitogen-activated protein kinase pathways, but not the NF-kappaB transcription factor family. J Immunol 168:316-24
17. Krisanaprakornkit S, Kimball JR, Weinberg A et al. (2000) Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 68:2907-15
18. Li M, Cha DJ, Lai Y et al. (2007a) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66:1136-47
19. Li M, Lai Y, Villaruz AE et al. (2007b) Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci USA 104: 9469-74
20. Liu AY, Destoumieux D, Wong AV et al. (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118:275-81
21. Meier F, Nesbit M, Hsu MY et al. (2000) Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol 156:193-200
22. Mempel M, Voelcker V, Kollisch G et al. (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121:1389-96
23. Menzies BE, Kenoyer A (2005) Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun 73:5241-4
24. Menzies BE, Kenoyer A (2006) Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 74:6847-54
25. Midorikawa K, Ouhara K, Komatsuzawa H et al. (2003) Staphylo-coccus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71:3730-9
26. Neish AS, Gewirtz AT, Zeng H et al. (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289:1560-3
27. Ogushi K, Wada A, Niidome T et al. (2001) Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells. J Biol Chem 276:30521-6
28. Pivarcsi A, Nagy I, Kemeny L (2005) Innate immunity in the skin: how keratinocytes fight against pathogens. Curr Immunol Rev 1:29-42
29. Schittek B, Paulmann M, Senyurek I et al. (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8:135-43
30. Schroder JM, Harder J (2006) Antimicrobial skin peptides and proteins. Cell Mol Life Sci 63:469-86
31. Sorensen OE, Cowland JB, Theilgaard-Monch K et al. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170:5583-9
32. Sorensen OE, Thapa DR, Rosenthal A et al. (2005) Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol 174:4870-9
33. Sorensen OE, Thapa DR, Roupe KM et al. (2006) Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116:1878-85
34. Tuzun Y, Antonov M, Dolar N et al. (2007) Keratinocyte cytokine and chemokine receptors. Dermatol Clin 25:467-76, vii
35. Voss E, Wehkamp J, Wehkamp K et al. (2006) NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281:2005-11
36. Wehkamp J, Harder J, Wehkamp K et al. (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72:5750-8
37. Wehkamp K, Schwichtenberg L, Schroder JM et al. (2006) Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 126:121-7